SCHEMBL16892153

SCHEMBL16892153

Cc1ccc(Oc2cc(N)cc(F)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEAD4 Q15561 1/20 0.59
ALDH1A1 P00352 5/20 0.57
MAPT P10636 4/20 0.57
TDP1 Q9NUW8 2/20 0.57
POLB P06746 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.55
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
NLRP3 Q96P20 1/20 0.46
F2 P00734 1/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
ST14 Q9Y5Y6 1/20 0.43
FFAR1 O14842 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8999880 0.90 MEN1 (0.53) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL22693618 0.86 MEN1 (0.50) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL8999877 0.84 MEN1 (0.43) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL1100004 0.82 MEN1 (0.47) ALDH1A1MAPTTDP1POLBSMN1; SMN2
SCHEMBL25396476 0.81 MAOA (0.59) ALDH1A1MAPTTDP1SMN1; SMN2MEN1
SCHEMBL30569458 0.81 MAOA (0.59) ALDH1A1MAPTTDP1SMN1; SMN2MEN1
SCHEMBL15396214 0.81 TEAD4 (0.63) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL16892154 0.81 ALDH1A1 (0.42) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL16892152 0.80 SLC6A2 (0.38) TEAD4ALDH1A1MAPTTDP1POLB
SCHEMBL15474260 0.79 ACHE (0.52) TEAD4ALDH1A1MAPTTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK TEAD4 1306/4885ALDH1A1 4521/4885MAPT 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.